HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LEADS BIOLABS-B

69.600

-1.600-2.25%

Volume:656.40K

Turnover:45.99M

Market Cap:13.85B

PE:-49.34

High:73.450

Open:73.350

Low:68.700

Close:71.200

52wk High:97.500

52wk Low:44.720

Shares:199.00M

HK Float Shares:198.00M

Volume Ratio:1.02

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.411

ROE:-27.61%

ROA:-9.92%

PB:9.39

PE(LYR):-49.34

PS:67.03

Loading ...

Overview Company News Filings

LEADS BIOLABS-B Surges Over 8% in Early Trading, Officially Added to Southbound Trading List

LEADS BIOLABS-B Surges Over 8% on Inclusion in Stock Connect and Clinical Trial Milestone

LEADS BIOLABS-B to Join Hang Seng Composite Index and Become Eligible for Southbound Trading

LEADS BIOLABS-B (09887) Announces Inclusion in Hang Seng Composite Index and Southbound Trading Link

Bulletin Express

LEADS BIOLABS-B (09887) Included in Hang Seng Composite Index and Added to Stock Connect List

Nanjing Leads Biolabs Joins Hang Seng Composite IndexNanjing Leads Biolabs Co., Ltd. said its shares will be added to the Hang Seng Composite Index effective March 9, 2026, and will also be included in the Stock Connect Southbound Trading Link eligible list

LEADS BIOLABS-B (Stock Code: 09887) Announces First Patient Enrolled in Phase II Trial for Opamtistomig in First-Line Esophageal Squamous Cell Carcinoma

Bulletin Express

LEADS BIOLABS-B (09887): First Patient Enrolled in Phase II Trial for VELISIN™ in First-Line Esophageal Squamous Cell Carcinoma

Nanjing Leads Biolabs Enrolls First Patient in Phase II ESCC Trial of LBL-024

Nanjing Leads Biolabs (09887) Releases February 2026 Monthly Return

Bulletin Express

LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/09887/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"LEADS BIOLABS-B","latestPrice":69.6,"timestamp":1787540709670,"preClose":71.2,"halted":0,"volume":656400,"delay":0,"changeRate":-0.022471910112359668,"floatShares":198000000,"shares":199000000,"eps":-1.4105711934156377,"marketStatus":"Trading","change":-1.6,"latestTime":"08-24 11:05:53","open":73.35,"high":73.45,"low":68.7,"amount":45992842,"amplitude":0.066713,"askPrice":69.6,"askSize":2200,"bidPrice":69.45,"bidSize":39600,"shortable":3,"etf":0,"ttmEps":-1.3721010699588476,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1787544000000},"marketStatusCode":2,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":71.2,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"volumeRatio":1.022784,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":198000000,"roa":"-9.92%","roe":"-27.61%","lyrEps":-1.410603,"volumeRatio":1.022784,"shares":199000000,"dividePrice":0,"high":73.45,"amplitude":0.066713,"preClose":71.2,"low":68.7,"week52Low":44.72,"pbRate":"9.39","psRate":"67.03","week52High":97.5,"institutionHeld":0,"latestPrice":69.6,"committee":0.894737,"eps":-1.4106027921268607,"divideRate":0,"volume":656400,"delay":0,"ttmEps":-1.3721318068870374,"open":73.35,"prevYearClose":51,"prevWeekClose":71.2,"prevMonthClose":53.4,"prevQuarterClose":49.32,"fiveDayClose":74.9,"twentyDayClose":58.05,"sixtyDayClose":60.85,"earningDate":1788105600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-27","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1780070400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2026-08-21","current":-50.725126,"percent":0.129278,"low":-76.458084,"twenty":-45.096211,"median":-39.845109,"eighty":-34.555887,"high":-30.202688,"avg":-41.975218,"sd":9.878337,"marketCap":14161096160},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375},{"date":"2025-08-29","current":-41.462871,"twenty":-44.683717,"median":-42.745269,"eighty":-41.268557,"marketCap":13146747980},{"date":"2025-09-05","current":-41.718992,"twenty":-44.115151,"median":-41.93996,"eighty":-40.603026,"marketCap":13087080440},{"date":"2025-09-12","current":-41.612383,"twenty":-43.894587,"median":-41.766832,"eighty":-40.253447,"marketCap":13077135850},{"date":"2025-09-19","current":-40.406926,"twenty":-43.894587,"median":-41.814673,"eighty":-40.270938,"marketCap":12689296840},{"date":"2025-09-26","current":-39.940552,"twenty":-43.592616,"median":-41.710721,"eighty":-39.940552,"marketCap":12510294220},{"date":"2025-10-03","current":-46.021818,"twenty":-44.124681,"median":-41.829747,"eighty":-40.190868,"marketCap":14449489270},{"date":"2025-10-10","current":-44.344385,"twenty":-44.480118,"median":-41.935668,"eighty":-40.263942,"marketCap":13902536820},{"date":"2025-10-17","current":-41.267963,"twenty":-44.480118,"median":-42.061577,"eighty":-40.352531,"marketCap":12927967000},{"date":"2025-10-24","current":-37.571928,"twenty":-44.331016,"median":-41.888099,"eighty":-40.263942,"marketCap":11774394560},{"date":"2025-10-31","current":-34.030535,"twenty":-44.258383,"median":-41.766832,"eighty":-39.846145,"marketCap":10680489660},{"date":"2025-11-07","current":-37.063837,"twenty":-44.143742,"median":-41.612383,"eighty":-39.421071,"marketCap":11625225710},{"date":"2025-11-14","current":-37.306884,"twenty":-44.026925,"median":-41.504614,"eighty":-38.171485,"marketCap":11734616200},{"date":"2025-11-21","current":-32.263354,"twenty":-43.773799,"median":-41.293984,"eighty":-37.626872,"marketCap":10143481800},{"date":"2025-11-28","current":-33.407237,"twenty":-43.416049,"median":-41.25873,"eighty":-37.278832,"marketCap":10541265400},{"date":"2025-12-05","current":-32.531883,"twenty":-43.110759,"median":-40.854935,"eighty":-36.232015,"marketCap":10282706060},{"date":"2025-12-12","current":-33.445348,"twenty":-43.033782,"median":-40.504976,"eighty":-34.804627,"marketCap":10590988350},{"date":"2025-12-19","current":-31.455565,"twenty":-42.962519,"median":-40.253447,"eighty":-33.697999,"marketCap":9984368360},{"date":"2025-12-24","current":-31.920084,"twenty":-42.892338,"median":-39.907071,"eighty":-33.445348,"marketCap":10163370980},{"date":"2026-01-02","current":-31.421623,"twenty":-42.818917,"median":-39.811672,"eighty":-33.24713,"marketCap":10044035900},{"date":"2026-01-09","current":-34.757237,"twenty":-42.712093,"median":-39.628079,"eighty":-33.303022,"marketCap":11137940800},{"date":"2026-01-16","current":-34.953981,"twenty":-42.570843,"median":-39.220132,"eighty":-33.387129,"marketCap":11237386700},{"date":"2026-01-23","current":-34.708884,"twenty":-42.534258,"median":-38.04671,"eighty":-33.234922,"marketCap":11147885390},{"date":"2026-01-30","current":-41.208386,"twenty":-42.402729,"median":-37.93488,"eighty":-33.285275,"marketCap":13295916830},{"date":"2026-02-06","current":-38.552413,"twenty":-42.362692,"median":-38.04671,"eighty":-33.303022,"marketCap":12470515860},{"date":"2026-02-13","current":-37.506904,"twenty":-42.335079,"median":-38.011119,"eighty":-33.387129,"marketCap":12202011930},{"date":"2026-02-20","current":-39.795685,"twenty":-42.275235,"median":-38.202679,"eighty":-33.413439,"marketCap":12927967000},{"date":"2026-02-27","current":-37.9711,"twenty":-42.061223,"median":-38.358648,"eighty":-33.438876,"marketCap":12470515860},{"date":"2026-03-06","current":-32.876582,"twenty":-42.035836,"median":-37.973315,"eighty":-33.326804,"marketCap":10710323430},{"date":"2026-03-13","current":-37.800338,"twenty":-41.938243,"median":-37.9711,"eighty":-33.411645,"marketCap":12371069960},{"date":"2026-03-20","current":-39.652105,"twenty":-41.914066,"median":-38.162788,"eighty":-33.431073,"marketCap":12927967000},{"date":"2026-03-27","current":-45.563334,"twenty":-41.938243,"median":-38.422097,"eighty":-33.438876,"marketCap":14817439100},{"date":"2026-04-02","current":-73.055706,"twenty":-42.061577,"median":-38.676054,"eighty":-33.441386,"marketCap":17572695150},{"date":"2026-04-10","current":-74.98239,"twenty":-42.364587,"median":-38.815397,"eighty":-33.443763,"marketCap":18175244000},{"date":"2026-04-17","current":-69.940613,"twenty":-42.73421,"median":-39.081216,"eighty":-33.482556,"marketCap":16960268450},{"date":"2026-04-24","current":-67.940785,"twenty":-43.090538,"median":-39.261059,"eighty":-33.558052,"marketCap":16476253800},{"date":"2026-04-30","current":-65.13036,"twenty":-44.026925,"median":-39.582143,"eighty":-33.605745,"marketCap":15804560000},{"date":"2026-05-08","current":-55.847576,"twenty":-44.547984,"median":-39.760016,"eighty":-33.640661,"marketCap":16030679080},{"date":"2026-05-15","current":-43.849045,"twenty":-45.37348,"median":-39.795589,"eighty":-33.697999,"marketCap":12619684710},{"date":"2026-05-22","current":-44.434352,"twenty":-44.931837,"median":-39.87359,"eighty":-33.778461,"marketCap":12758908970},{"date":"2026-05-29","current":-42.313126,"twenty":-44.693978,"median":-39.965338,"eighty":-33.850015,"marketCap":12192067340},{"date":"2026-06-05","current":-38.943344,"twenty":-44.633844,"median":-39.952945,"eighty":-33.989804,"marketCap":11237386700},{"date":"2026-06-12","current":-37.176407,"twenty":-44.416359,"median":-39.831455,"eighty":-34.116239,"marketCap":10720268020},{"date":"2026-06-18","current":-37.166904,"twenty":-44.344385,"median":-39.795685,"eighty":-34.459057,"marketCap":10740157200},{"date":"2026-06-26","current":-34.282345,"twenty":-44.322103,"median":-39.774315,"eighty":-34.282345,"marketCap":9861055444},{"date":"2026-07-03","current":-36.446991,"twenty":-44.194662,"median":-39.640092,"eighty":-34.070689,"marketCap":10491542450},{"date":"2026-07-10","current":-34.534018,"twenty":-44.124681,"median":-39.536207,"eighty":-34.070689,"marketCap":9928678656},{"date":"2026-07-17","current":-44.462046,"twenty":-44.326559,"median":-39.640092,"eighty":-34.242022,"marketCap":12828521100},{"date":"2026-07-24","current":-43.03924,"twenty":-44.356568,"median":-39.788614,"eighty":-34.393423,"marketCap":12420792910},{"date":"2026-07-31","current":-36.732388,"twenty":-44.331016,"median":-39.652105,"eighty":-34.443911,"marketCap":10620822120},{"date":"2026-08-07","current":-44.144483,"twenty":-44.255348,"median":-39.774315,"eighty":-34.478204,"marketCap":12788742740},{"date":"2026-08-14","current":-50.259709,"twenty":-44.44543,"median":-39.795685,"eighty":-34.516798,"marketCap":14578768940},{"date":"2026-08-21","current":-48.712147,"twenty":-45.096211,"median":-39.845109,"eighty":-34.555887,"marketCap":14161096160}],"updateTime":1787540753250},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1189430822","title":"LEADS BIOLABS-B Surges Over 8% in Early Trading, Officially Added to Southbound Trading List","url":"https://stock-news.laohu8.com/highlight/detail?id=1189430822","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189430822?lang=en_us&edition=fundamental","pubTime":"2026-03-09 10:44","pubTimestamp":1773024294,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) saw an increase of more than 8% at the start of trading. At the time of writing, the stock was up 6.04%, trading at HK$57.10, with a turnover of HK$115 million. The company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","VXUS","09887","BK4588","VT","HK0000252160.HKD","HK0000500386.USD","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195884849","title":"LEADS BIOLABS-B Surges Over 8% on Inclusion in Stock Connect and Clinical Trial Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1195884849","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195884849?lang=en_us&edition=fundamental","pubTime":"2026-03-09 10:34","pubTimestamp":1773023659,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) rose more than 8%. At the time of writing, the stock was up 8.08% to HK$58.05, with a turnover of HK$110 million. On the news front, LEADS BIOLABS announced that, effective...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VT","HK0000500386.USD","09887","HK0000252152.HKD","BK4588","BK4585","HK0000252160.HKD","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199922475","title":"LEADS BIOLABS-B to Join Hang Seng Composite Index and Become Eligible for Southbound Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1199922475","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199922475?lang=en_us&edition=fundamental","pubTime":"2026-03-08 10:20","pubTimestamp":1772936446,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and will...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCI","BK4588","VXUS","BK1161","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","BK4585","09887","VT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136889806","title":"LEADS BIOLABS-B (09887) Announces Inclusion in Hang Seng Composite Index and Southbound Trading Link","url":"https://stock-news.laohu8.com/highlight/detail?id=1136889806","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136889806?lang=en_us&edition=fundamental","pubTime":"2026-03-06 17:23","pubTimestamp":1772789002,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co., Ltd. (LEADS BIOLABS-B) (Stock Code: 09887) announced that, effective March 9, 2026, its shares will be included as a constituent stock of the Hang Seng Composite Index by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188540988","title":"LEADS BIOLABS-B (09887) Included in Hang Seng Composite Index and Added to Stock Connect List","url":"https://stock-news.laohu8.com/highlight/detail?id=1188540988","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188540988?lang=en_us&edition=fundamental","pubTime":"2026-03-06 17:18","pubTimestamp":1772788704,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and added...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HK0000252160.HKD","HSCI","VT","HK0000252152.HKD","BK1161","BK4585","HK0000500386.USD","09887","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617468687","title":"Nanjing Leads Biolabs Joins Hang Seng Composite IndexNanjing Leads Biolabs Co., Ltd. said its shares will be added to the Hang Seng Composite Index effective March 9, 2026, and will also be included in the Stock Connect Southbound Trading Link eligible list","url":"https://stock-news.laohu8.com/highlight/detail?id=2617468687","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617468687?lang=en_us&edition=fundamental","pubTime":"2026-03-06 17:11","pubTimestamp":1772788313,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Joins Hang Seng Composite Index Nanjing Leads Biolabs Co., Ltd. said its shares will be added to the Hang Seng Composite Index effective March 9, 2026, and will also be included in the Stock Connect Southbound Trading Link eligible list. Nanjing Leads Biolabs Co., Ltd.  said its shares will be added as a constituent of the Hang Seng Composite Index effective March 9, 2026. The company said the inclusion reflects capital market recognition of its performance and value and is expected to broaden its investor base and improve trading liquidity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanjing Leads Biolabs Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL2Gf8sH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","BK1161","HK0000500386.USD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178792306","title":"LEADS BIOLABS-B (Stock Code: 09887) Announces First Patient Enrolled in Phase II Trial for Opamtistomig in First-Line Esophageal Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1178792306","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178792306?lang=en_us&edition=fundamental","pubTime":"2026-03-06 16:51","pubTimestamp":1772787065,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of the announcement referenced here, make no representation as to its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147752592","title":"LEADS BIOLABS-B (09887): First Patient Enrolled in Phase II Trial for VELISIN™ in First-Line Esophageal Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1147752592","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147752592?lang=en_us&edition=fundamental","pubTime":"2026-03-06 16:38","pubTimestamp":1772786322,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) announced that the first patient has been successfully enrolled in a Phase II clinical study evaluating VELISIN™ (PD-L1/4-1BB bispecific antibody, Opatisumimab, LBL-024) for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK1161","HK0000252152.HKD","09887","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617684683","title":"Nanjing Leads Biolabs Enrolls First Patient in Phase II ESCC Trial of LBL-024","url":"https://stock-news.laohu8.com/highlight/detail?id=2617684683","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617684683?lang=en_us&edition=fundamental","pubTime":"2026-03-06 16:32","pubTimestamp":1772785929,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co. Ltd. said the first patient has been enrolled in an open-label, multi-center Phase II clinical study of Opamtistomig , a PD-L1/4-1BB bispecific antibody, for first-line esophageal squamous cell carcinoma in China. The company said the trial, led by Professor Shen Lin of Beijing Cancer Hospital, will evaluate the efficacy and safety of Opamtistomig in first-line ESCC patients. The company also provided development updates for LBL-024 in extrapulmonary neuroendocrine carcinoma, including National Medical Products Administration approval in April 2024 for a single-arm registrational trial, Breakthrough Therapy Designation from the NMPA in October 2024 for late-line advanced EP-NEC, FDA Orphan Drug Designation for neuroendocrine carcinoma in November 2024, FDA Fast Track Designation for EP-NEC in January 2026, and European Commission Orphan Drug Designation for EP-NEC in January 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL8DBrpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","BK1161","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146295038","title":"Nanjing Leads Biolabs (09887) Releases February 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1146295038","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146295038?lang=en_us&edition=fundamental","pubTime":"2026-03-03 12:44","pubTimestamp":1772513097,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co., Ltd. (09887) published its monthly return for the period ended 28 February 2026, reporting no changes in issued share capital during the month. The total authorized share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199865714","title":"LEADS BIOLABS-B Shares Surge 6% in Afternoon Session on Potential Inclusion in Southbound Trading Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1199865714","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199865714?lang=en_us&edition=fundamental","pubTime":"2026-02-23 15:00","pubTimestamp":1771830019,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) saw its share price increase by 6% in the afternoon session, currently trading at HK$68.90, with a turnover of HK$30.7841 million. Following the recent quarterly review...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK4585","BK1161","VXUS","VT","09887","HK0000252152.HKD","BK4588","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":7,"totalSize":131,"code":"91000000","status":"200"}]}}